| Literature DB >> 27003245 |
Nicholas Edward Ilott1, Julia Bollrath1,2, Camille Danne1, Chris Schiering3, Matthew Shale4, Krista Adelmann1, Thomas Krausgruber5, Andreas Heger6, David Sims6, Fiona Powrie1.
Abstract
The gut microbiome is significantly altered in inflammatory bowel diseases, but the basis of these changes is not well understood. We have combined metagenomic and metatranscriptomic profiling of the gut microbiome to assess modifications to both bacterial community structure and transcriptional activity in a mouse model of colitis. By using transcriptomic analysis of colonic tissue and luminal RNA derived from the host, we have also characterised how host transcription relates to the microbial transcriptional response in inflammation. In colitis, increased abundance and transcription of diverse microbial gene families involved in responses to nutrient deprivation, antimicrobial peptide production and oxidative stress support an adaptation of multiple commensal genera to withstand a diverse set of environmental stressors in the inflammatory environment. These data are supported by a transcriptional signature of activated macrophages and granulocytes in the gut lumen during colitis, a signature that includes the transcription of the key antimicrobial genes S100a8 and S100a9 (calprotectin). Genes involved in microbial resistance to oxidative stress, including Dps/ferritin, Fe-dependent peroxidase and glutathione S-transferase were identified as changing to a greater extent at the level of transcription than would be predicted by DNA abundance changes, implicating a role for increased oxygen tension and/or host-derived reactive oxygen species in driving transcriptional changes in commensal microbes.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27003245 PMCID: PMC5030693 DOI: 10.1038/ismej.2016.40
Source DB: PubMed Journal: ISME J ISSN: 1751-7362 Impact factor: 10.302
Figure 1Microbial community composition across samples. (a) Overview of the experimental setup and number of mice in each group. (b) Histological assessment of mouse colon for mice in each group at day 14 of the model. (c) The average cumulative proportion of metagenomic reads assigned to genera. (d) The average cumulative proportion of metatranscriptomic reads assigned to genera. (e) The genera that constitute the majority of the metagenomic data (>5% assigned reads). (f) The genera that constitute the majority of the metatranscriptomic data (>5% assigned reads). H. h=H. hepaticus.
Figure 2Differentially abundant genera in colitis versus steady state. (a) Overlap of genera detected with ⩾1 read in ⩾1 sample in metagenomic and metatranscriptomic analyses. (b) Distributions of reads per million (RPM) for genera detected in DNA-seq, RNA-seq or both data sets (average across 16 samples). *Wilcoxon rank-sum test P<0.05. (c) Correlation between genus abundance estimates (log2) of 669 genera detected at abundance >0.1 RPM in both data sets. (d) PCA of metagenomeSeq normalised genus abundances (669 genera detected at >0.1 RPM in both data sets) in metagenomic analysis. (e) PCA of metagenomeSeq normalised genus abundances (669 genera detected at >0.1 RPM in both data sets) in metatranscriptomic analysis. (f) PCA of metagenomeSeq normalised genus abundances (652 genera detected at >0.1 RPM in both RNA-seq data sets) in a replication metatranscriptomic data set. (g) Gene set enrichment analysis (GSEA) using the genera identified as significantly increased in abundance in the replication data set as the gene set for enrichment testing in the initial data set. The initial data set was ranked by fold change (high to low) in the comparison between colitis and steady state and tested for a significant enrichment at the top of the list using GSEA and permuted genus ranks with 1000 permutations as shown in (h). (i) GSEA of genera significantly decreased in colitis in the replication data set with the initial data ranked by fold change (low to high). Significance testing was again performed using 1000 permutations of genus rank as shown in (j). (k) Genera identified as being significantly differentially abundant in the replication metatranscriptomic data set and that contributed to the enrichment at the top of the ranked lists in (g) and (i) i.e. occurred in the ranked list before the maximum enrichment score was reached (the so-called ‘leading edge’ subset).
Figure 3Functional profiling of the gut microbiota using metagenomics and metatranscriptomics. (a) The eggNOG functional categories that constitute the majority of the metagenomic data (>5% assigned reads). (b) The eggNOG functional categories that constitute the majority of the metatranscriptomic data (>5% assigned reads). (c) Metatranscriptomic reads were selected that could be assigned to both a genus and a NOG (average number of reads=6.3 M) and the proportion of genera that expressed any NOG in each of the eggNOG functional categories was plotted. (d) A breakdown of the genera that contributed to the transcription of the top 10 most highly abundant NOGs in the eggNOG functional category carbohydrate transport and metabolism. Only genera that contributed >1% of metatranscriptomic reads to any given NOG are shown.
Figure 4Identification of differentially abundant NOGs at the level of DNA and transcription. (a) Overlap of NOGs detected with ⩾1 read in ⩾1 sample in metagenomic and metatranscriptomic analyses. (b) Distributions of reads per million (RPM) for NOGs detected in DNA-seq, RNA-seq or both data sets (average across 16 samples). *Wilcoxon rank-sum test P<0.05. (c) Correlation between NOG abundance estimates (log2) of 14 211 NOGs that were detected at an abundance of >0.1 RPM in both data sets. (d) PCA of metagenomeSeq normalised NOG abundances (14 211 NOGs detected in both data sets at >0.1 RPM) in the metagenomic data set. (e) PCA of metagenomeSeq normalised NOG abundances (14 211 NOGs detected in both data sets at >0.1 RPM) in the metatranscriptomic data set. (f) Overlap of NOGs called as differentially abundant (adjusted P<0.05 in H. h+aIL10R (colitis) versus steady state) in metagenomic and metatranscriptomic data sets. (g) Fold enrichment of NOG functional categories in the set of NOGs that were found to be more highly abundant and transcribed in colitis versus steady state in both metagenomic and metatranscriptomic data sets. (h) Normalised RNA abundance of NOGs in the inorganic ion transport and metabolism eggNOG functional category that were found to be more highly abundant and transcribed in colitis versus steady state in both metagenomic and metatranscriptomic data sets. (i) The proportion of metatranscriptomic reads from each genus that contributed to transcription of each NOG identified in (h). Only those genera that contributed >1% of metatranscriptomic reads to any given NOG are shown. (j) Correlation of NOG abundance estimates (log2) across replicate metatranscriptomic data sets. The mean abundance across samples is plotted in each case. (k) Overlap of NOGs called as significantly differentially abundant (Benjamini-Hochberg adjusted P-value <0.05) across replicate metatranscriptomic data sets. The significance of the overlap was calculated using the hypergeometric test.
Figure 5Transcription of upregulated, colitis-responsive NOGs is dominated by Lactobacillus and Bacteroides. (a) Correlation of fold changes between metagenomic and metatranscriptomic analyses. The solid line represents the linear model fit and dashed lines represent the 95% prediction intervals. NOGs lying outside of the 95% prediction intervals and that were called as differentially regulated in metatranscriptomic analysis were defined as colitis-responsive. (b) Metatranscriptomic reads were selected that mapped to both a genus and NOG (mean=6.3 M reads). The percentage of reads from each genus that contributed to NOG expression was calculated for all NOGs and the cumulative proportion was plotted for each NOG set. Significant differences in distributions were assessed using the Kolmogorov-Smirnov test for each set against the non-significant (NS) set of NOGs. (c) Heatmap displaying the percentage of metatranscriptomic reads (average across all samples) derived from each genus contributing to NOGs defined as being upregulated and colitis-responsive. Only those NOGs that have a major genus contributor (i.e., >50% contribution) are displayed. MetagenomeSeq was run on counts per genus per NOG and genera/NOG fold changes (log2) from metagenomic and metatranscriptomic analyses were plotted for genera that expressed (d) COG0783: Dps/ferritin (e) COG2837: Fe-dependent peroxidase and (f) COG0435: glutathione S-transferase. Points and text are scaled by relative RNA abundance. The blue solid line represents y=x. Solid black lines are where log2 (fold change) is 0 and dashed lines represent two fold changes.
Figure 6Luminal expression of host genes represents a signature of activated innate cells. (a) Experimental setup for characterising gene expression changes over the course of the colitis model. (b) Heatmap of colonic tissue transcriptional changes (LIMMA adjusted P<0.05) across time in the H. h+aIL10R model of colitis. Colours on the left panel represent cluster assignments for genes using k-means clustering (k=3). Gene Ontology (GO) biological processes that are significantly (Benjamini-Hochberg adjusted P<0.05) enriched for each cluster are labelled. (c) Differential expression analysis of mouse genes detected using RNA-seq from faecal samples between steady state and H. h+aIL10R (colitic) mice. Genes annotated as being involved in the antimicrobial defence response (GO biological process) are labelled. Dashed lines represent fold changes ⩽−2 and ⩾2. Blue=DESeq adjusted P<0.05. (d) Cell-type enrichment analysis of mouse genes identified as being more highly abundant in H. h+aIL10R (colitic) faeces compared to steady state. The top 10 enriched cell types are shown.